Spain vs Uzbekistan: Cause of death, by non-communicable diseases, female
Spain
85.4%
in 2021
Uzbekistan
85.0%
in 2021
Spain rank
14th
Uzbekistan rank
17th
Cause of death, by non-communicable diseases, female over time
- Spain
- Uzbekistan
How they compare
Spain currently reports 85.4% against 85.0% in Uzbekistan, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Spain ahead.
Spain ranks 14th and Uzbekistan ranks 17th of 185 countries.
Across the 3 decades both report, Spain averaged higher in 2 and Uzbekistan in 1.
Head to head by decade
| Decade | Spain | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.4% | 81.7% | 10.7% | Spain |
| 2010s | 92.1% | 89.8% | 2.2% | Spain |
| 2020s | 81.9% | 85.6% | 3.7% | Uzbekistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Spain or Uzbekistan?
- Spain, at 85.4% against 85.0% in Uzbekistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Spain and Uzbekistan?
- 0.4%, with Spain ahead.
- How many years of comparable data are there for Spain and Uzbekistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Spain and Uzbekistan rank globally for cause of death, by non-communicable diseases, female?
- Spain ranks 14th and Uzbekistan ranks 17th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.